Good afternoon,
In this week’s update, I wanted to take a look at a stock we mentioned a few months, Teledoc.
Teladoc [TDOC] had stellar performance following COVID-19 because many patients began to increasingly book online appointments. Telehealth is one area of digital health that will not likely disappear, and Teladoc is a leader in this space.
However, it appears that shares of Teladoc have been left for dead, even though its financials have improved and many industry catalysts remain relevant. If Teladoc returned to its previous peak of 2021, shares would trade nearly 20x higher.
This current setup looks very appealing, given that Teladoc is moving towards profitability and could unleash new growth sources. The perceived risks of this investment appear much higher than the actual risks. Teladoc’s financial state has improved considerably since 2021, and shares could be in an attractive bottoming-out phase. Teladoc could surprise to the upside in the coming quarters.
